OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Internal Medicine is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Internists or specialists-that is the question!	424
Abdominal aortic aneurysm and gas in the kidney in a diabetes patient	182
The role of age in recognizing cognitive impairment in the emergency department	181
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus	134
Non-pharmacological home remedies used by primary care patients	118
Effects of the implementation of the dynamic silver code in the emergency department	104
The higher the serum albumin, the better? Findings from the PRACTICE study	92
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)	92
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis	75
Trial sequential analysis methodology for interpreting meta-analytical findings	75
The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125	67
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes	65
Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis	63
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality	59
No evidence of a “July Effect” on mortality	56
Heart failure: An autopsy case	56
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease	54
The peculiarities of COVID-19 in older people: Considerations after two years	54
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?	52
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation	51
Prognostic impact of hypertension grading	50
Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation	49
A woman with purple-brown skin lesions after immunosuppressive therapy	49
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research	46
Aspirin and P2Y12 inhibitors in treating COVID-19	45

Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines	44
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes	43
Refining metabolic health assessment in inflammatory bowel disease risk prediction	42
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients	42
Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)	41
Systolic blood pressure, a predictor of mortality and life expectancy following heart failure hospitalization, 2010–2023	40
Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients	39
Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation	37
Optimal duration of anticoagulation therapy for venous thromboembolism in autoimmune diseases	37
Different impact of chronic kidney disease in older patients with heart failure according to frailty	36